Autoimmune ataxic neuropathies (sensory ganglionopathies): Are glycolipids the responsible autoantigens?
M. Dalakas,R. Quarles
DOI: https://doi.org/10.1002/ana.410390402
IF: 11.2
1996-04-01
Annals of Neurology
Abstract:Sensory ataxic neuropathies (SANS) are characterized by profound loss of kinesthetic sensation (proprioception and vibration) and remarkable preservation of muscle strength [I] . In contrast, in the other polyneuropathies the cutaneous sensation (light touch and pain) are predominantly affected, and by the time the proprioceptive modalities are involved, motor weakness is almost always present. In the upper extremities, the impaired or absent proprioception may cause pseudoathetosis of fingers and wrists. In the lower extremities, there is ataxia of gait, positive Romberg’s sign, and, in severe cases, inability to stand without assistance. In spite of the resemblance to cerebellar disease, true cerebellar signs such as titubation, truncal ataxia, or dysarthria are absent. Most remarkably, postural maintenance and voluntary hand movements are heavily dependent on visual guidance [2], as reflected by frightening experiences reported by these patients when they found themselves suddenly in the dark [I] . The lesion is in the dorsal root ganglia (ganglionopathy) resulting in loss of the large ganglionic neurons and axonal degeneration of the large sensory axons [ 1, 31. At times, proximal demyelination, at the dorsal root level, is also evident. Motor nerve conduction velocity is usually normal or slightly slow, sensory potentials are absent, and the sural nerve biopsy shows selective loss of the large myelinated axons [I] . SANS may start acutely, or more often slowly. The various causes of SANS and its associated disorders are listed in the Table [ l , 3-61. The ataxic rieuropatby associated with GDl b mtibodies. In 1985, we reported the first case of a SAN associated with an IgM monoclonal gammopathy [7] in which rhe IgM immunoreacted with G D l b and other gangliosides containing disialosyl groups, such as GD3, GD2, and G T l b , but not GM1, GM3, or G D l a (Fig). Six similar cases of SAN have been reported since then, including one of ours, suggesting that a subset of paraproteinemic IgM gammopathy patients with antibodies to gangliosides containing disialosyl groups comprise a homogeneous and rather distinct entity [7-131. Athough antibodies against GDlb are also seen in many patients with motor neuron syndromes and mixed sensorimotor neuropathies [6], in these cases the IgM also recognizes G M 1 or other gangliosides without disialosyl moieties, ie, the Gal (Pl-3) GalNAc epitope, which is present in both G M I and GDlb (see Fig). The report by Kusunoki and associates [I41 that immunization of rabbits with G D l b caused a SAN with areflexia, ataxia, and normal strength, as clinically seen i n the human disease, offers a new model of autoimmune neuropathy and opens the avenues of exploring the role of G D l b or other gangliosides with disialosyl groups as the responsible antigens in the cause of sensory ataxia. The dorsal root ganglionic neurons of the immunized rabbits expressed G D l b and were selectively involved, resembling the pattern observed in the ganglia of patients with SAN. Is GDlb the target antigen? Although G D l b has in common with GMl the Gal (PI-3) GalNAc epitope, which is also shared by glycoproteins, the NeuNAc (0r2-8) NeuNAc moiety is present only in the G D l b structure (see Fig). It appears that when IgM recognizes the Gal (pl-3) GalNAc moiety of GM1, which is found on the surface of the motor ncurons, there is clinically a motor neuropathy. In contrast, if the IgM recognizes epitopes containing disialosyl groups of G D l b , which is present on the surface of the dorsal root ganglionic neurons [ 151, there is clinically a sensory neuropathy. Thus, the sugar structure of the reactive gangliosides may determine cellular specificity, antigenic targets and the ensuing clinical manifestation. It is not clear, however, if G D l b , which is quantitatively the most reactive ganglioside of human peripheral nerve [7, 81, or other gangliosides with disialosyl groups that the patients’ sera also recognize, is the most